spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  oxygen therapeutic 

 HSMN NewsFeed - 29 Mar 2010
Oxygen Biotherapeutics Now Marketing New Formulation of Dermacyte(TM) Oxygen Concentrate
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 14 Aug 2009
Oxygen Biotherapeutics, Inc. to Begin Oxycyte(R) Phase II Clinical Trials in Switzerland
Biopharmaceuticals Neurology
 HSMN NewsFeed - 18 May 2009
U.S. Naval Medical Research Center Proposed 'RESUS' Clinical Trial in Trauma Patients Remains on FDA Hold
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Mar 2009
Oxygen Biotherapeutics, Inc. Establishes Warfighter Division
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Mar 2009
U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'RESUS' Clinical Trial in Trauma Patients in the Out-of-Hospital Setting
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Mar 2009
Oxygen Biotherapeutics, Inc. Receives Letter From FDA Outlining Path Forward to Resume Oxycyte Clinical Trials in TBI in U.S.A.
Devices FDA
 HSMN NewsFeed - 17 Mar 2009
Oxygen Biotherapeutics, Inc. to Launch Product Line of Oxycyte(R) Gels for the Over-the-Counter Market
Devices Biopharmaceuticals
 HSMN NewsFeed - 2 Feb 2009
Molecular Insight Pharmaceuticals Announces Board and Senior Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jan 2009
Oxygen Biotherapeutics, Inc. Submits Request for Designation to FDA for Oxycyte(R)-based Wound Care Product
Devices Wound Care FDA
 HSMN NewsFeed - 8 Jan 2009
Sangart, Inc. Announces Key Executive Appointments and Company Restructuring
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Dec 2008
U.S. Navy Requested Operations Trial on FDA Hold
Biopharmaceuticals
 HSMN NewsFeed - 28 Oct 2008
Biopure Sues National Institutes of Health Official
Biopharmaceuticals
 HSMN NewsFeed - 22 Sep 2008
Oxygen Biotherapeutics, Inc. Announces License Agreement for Its Glucose Biosensor Technology
Devices Monitoring Licensing
 HSMN NewsFeed - 12 Sep 2008
Oxygen Biotherapeutics, Inc. Names Robert F. Diegelmann to Lead New Wound Care Division
Devices Wound Care Personnel
 HSMN NewsFeed - 12 Aug 2008
Oxygen Biotherapeutics Develops Gel Version of Oxycyte(R) for Treating Surface Wounds
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 1 Jul 2008
Synthetic Blood International Changes Name to Oxygen Biotherapeutics, Inc.
Biopharmaceuticals
 HSMN NewsFeed - 8 May 2008
U.S. Navy Receives Funding for Further Development of Hemopure(R)
Biopharmaceuticals
 HSMN NewsFeed - 22 Apr 2008
Synthetic Blood International, Inc. to Seek Shareholder Approval for Name Change
Biopharmaceuticals
 HSMN NewsFeed - 7 Apr 2008
Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 4 Apr 2008
Synthetic Blood International, Inc. Announces Plans to File Protocol for Phase II-b Oxycyte(R) Clinical Trial
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 31 Mar 2008
Synthetic Blood International, Inc. Announces New Leadership Roles to Continue Product Development Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2008
Synthetic Blood International, Inc. Announces Passing of Interim CEO Robert Larsen
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Mar 2008
Office of Naval Research Provides $3.5 Million in New Grants for Clinical Research Involving Synthetic Blood International's Oxycyte(R)
Biopharmaceuticals
 HSMN NewsFeed - 26 Feb 2008
Synthetic Blood Announces Department of Defense Grant for Traumatic Brain Injury Clinical Trial with Oxycyte
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 8 Feb 2008
Synthetic Blood Announces Medical Advisory Board Meeting Results, New Additions to Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Dec 2007
Synthetic Blood Announces Oxycyte Development Strategy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Dec 2007
Independent Data Safety Monitoring Board Recommends Continuation of Sangart's Pivotal Phase III Trials of Hemospan(R)
Biopharmaceuticals
 HSMN NewsFeed - 11 Dec 2007
Synthetic Blood Announces Progress with Oxycyte Program in Traumatic Brain Injury
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 28 Nov 2007
Synthetic Blood Announces VCURES Receives $1.3 Million From U.S. Navy for Decompression Sickness Research with Oxycyte
Biopharmaceuticals
 HSMN NewsFeed - 20 Nov 2007
Synthetic Blood Announces Major Restructuring
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2007
Biopure Submits Complete Response to U.K. Regulatory Body on Marketing Application for Hemopure(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Oct 2007
Biopure Appoints Officer and Regains Nasdaq Listing Compliance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2007
Biopure Announces Expanded Clinical Program To Target Anemia
Biopharmaceuticals
 HSMN NewsFeed - 6 Sep 2007
Biopure Reports on Meeting with the FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Aug 2007
Biopure Seeks Compassionate Use Protocol for Treatment of Acute Anemia
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 May 2007
Positive Statistical Analysis from Synthetic Blood's Oxycyte Traumatic Brain Injury Trial Indicates Achievement of Primary Endpoint
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Jan 2007
Biopure Provides Further Comment on U.K. Regulatory Body Letter Regarding Marketing Application for Hemopure(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 10 Jan 2007
Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Dec 2006
Synthetic Blood Reports Positive Preliminary Results From Traumatic Brain Injury Clinical Trial
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 20 Dec 2006
Biopure Announces Next Steps for Navy's Proposed 'Resus' Trauma Trial of Hemopure(R)
Biopharmaceuticals
 HSMN NewsFeed - 18 Dec 2006
Advaxis Names Thomas A. Moore to Serve as CEO and Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Nov 2006
Biopure's Phase II Trauma Trial of Hemopure(R) in South Africa Continues Following Independent Panel's First Scheduled Interim Review
Biopharmaceuticals
 HSMN NewsFeed - 12 Sep 2006
Biopure's Marketing Application for Hemopure(R) Accepted for Review In United Kingdom
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 Jul 2006
Biopure Comments on Wall Street Journal Articles
Biopharmaceuticals
 HSMN NewsFeed - 12 Jul 2006
Synthetic Blood Updates Traumatic Brain Injury Trial Enrollment
Biopharmaceuticals
 HSMN NewsFeed - 11 Jul 2006
Biopure Applies for Marketing Authorization of Hemopure(R) In the United Kingdom
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 May 2006
FDA Advisory Committee to Consider Navy's Proposed 'RESUS' Trauma Trial at July 2006 Meeting
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 May 2006
Synthetic Blood Reaches First Half of Traumatic Brain Injury Trial
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2006
Biopure Appoints Vice President of Medical Affairs
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 46

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 46 additional stories matching:
oxygen therapeutic
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!